Blackstone closes $6.3bn life sciences fund
Tuesday, March 31, 2026 · first reported by Private Equity Wire
Blackstone raised $6.3bn for Blackstone Life Sciences VI, the largest life sciences PE fund ever, backing late-stage clinical trials and medical technologies.
- Firm
- Blackstone
- Fund
- Blackstone Life Sciences VI
- Size
- $6.3B
- Stage
- Final close
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Blackstone
Everything on this firm →- Blackstone poaches ex-InfraBridge co-head for London infra MD roleInfrastructure Investor
- Blackstone inks deal for TSC and ASEI to form defense platform FalcataPE Hub
- Blackstone to launch investment platform for Nordics warehousesReuters
- Blackstone’s Private Equity Chief Joe Baratta in Talks to ExitBloomberg +3
- Blackstone launches first multi-asset private markets fund for non-US investorsPrivate Equity Wire +6
- Apax Sets $13.5 Billion Target for Fund XIIWSJ
- Investcorp closes second North American PE fund at $1.22bnAlternatives Watch
- TPG Gets $10 Billion for Climate PE Fund; to Close for New CashBloomberg +2
- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- Ares raises $1.15bn for PE secondaries Fund IThe Secondary Brief
- Thompson Street targets $1.7bn for seventh flagship fundBuyouts Insider